Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle

Dmitry O. Traktuev, Zoya I. Tsokolaeva, Alexander A. Shevelev, Konstantin A. Talitskiy, Victoria V. Stepanova, Brian H. Johnstone, Tahmina M. Rahmat-Zade, Alexander N. Kapustin, Vsevolod A. Tkachuk, Keith L. March, Yelena V. Parfyonova

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Urokinase plasminogen activator (uPA) is required for both endogenous and vascular endothelial growth factor (VEGF)-augmented angiogenesis in normal tissues, leading us to hypothesize that uPA augmentation by gene transfer might promote angiogenesis in ischemic tissues. Overexpression of uPA was studied in rat myocardial infarction (MI) and mouse hind limb ischemia models and compared with VEGF overexpression effects. Animals were divided into control and three experimental groups (n = 6), receiving intramuscular injections of plasmids as follows: (i) control (empty vector or expressing β-galactosidase); (ii) uPA; (iii) VEGF165; (iv) a 1:1 mixture of uPA and VEGF165. The capillary densities in both ischemic models were greater (P < 0.05) in tissues treated with uPA, VEGF, or a combination of both than in controls. Infarct size was reduced in hearts from uPA and VEGF experimental groups compared with controls (P < 0.05). Local overexpression of uPA induced a marked increase in the number of macrophages and myofibroblasts present within infarcts. Hind limb blood flow was greater in all experimental groups by day 10 (P < 0.05). Overall, the effects of uPA and VEGF were uniformly comparable. Additional analysis revealed association of local edema with VEGF but not with uPA treatment. This study established that uPA gene therapy effectively induces functionally significant angiogenesis in models of acute MI and hind limb ischemia.

Original languageEnglish (US)
Pages (from-to)1939-1946
Number of pages8
JournalMolecular Therapy
Volume15
Issue number11
DOIs
StatePublished - Nov 2007

Fingerprint

Plasminogen Activators
Urokinase-Type Plasminogen Activator
Skeletal Muscle
Vascular Endothelial Growth Factor A
Genes
Extremities
Ischemia
Myocardial Infarction
Galactosidases
Myofibroblasts
Intramuscular Injections
Genetic Therapy
Edema
Plasmids
Macrophages

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

Traktuev, D. O., Tsokolaeva, Z. I., Shevelev, A. A., Talitskiy, K. A., Stepanova, V. V., Johnstone, B. H., ... Parfyonova, Y. V. (2007). Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. Molecular Therapy, 15(11), 1939-1946. https://doi.org/10.1038/sj.mt.6300262

Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. / Traktuev, Dmitry O.; Tsokolaeva, Zoya I.; Shevelev, Alexander A.; Talitskiy, Konstantin A.; Stepanova, Victoria V.; Johnstone, Brian H.; Rahmat-Zade, Tahmina M.; Kapustin, Alexander N.; Tkachuk, Vsevolod A.; March, Keith L.; Parfyonova, Yelena V.

In: Molecular Therapy, Vol. 15, No. 11, 11.2007, p. 1939-1946.

Research output: Contribution to journalArticle

Traktuev, DO, Tsokolaeva, ZI, Shevelev, AA, Talitskiy, KA, Stepanova, VV, Johnstone, BH, Rahmat-Zade, TM, Kapustin, AN, Tkachuk, VA, March, KL & Parfyonova, YV 2007, 'Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle', Molecular Therapy, vol. 15, no. 11, pp. 1939-1946. https://doi.org/10.1038/sj.mt.6300262
Traktuev DO, Tsokolaeva ZI, Shevelev AA, Talitskiy KA, Stepanova VV, Johnstone BH et al. Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. Molecular Therapy. 2007 Nov;15(11):1939-1946. https://doi.org/10.1038/sj.mt.6300262
Traktuev, Dmitry O. ; Tsokolaeva, Zoya I. ; Shevelev, Alexander A. ; Talitskiy, Konstantin A. ; Stepanova, Victoria V. ; Johnstone, Brian H. ; Rahmat-Zade, Tahmina M. ; Kapustin, Alexander N. ; Tkachuk, Vsevolod A. ; March, Keith L. ; Parfyonova, Yelena V. / Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. In: Molecular Therapy. 2007 ; Vol. 15, No. 11. pp. 1939-1946.
@article{9a7410d1eb0c4607a02c1fc5ffa60f34,
title = "Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle",
abstract = "Urokinase plasminogen activator (uPA) is required for both endogenous and vascular endothelial growth factor (VEGF)-augmented angiogenesis in normal tissues, leading us to hypothesize that uPA augmentation by gene transfer might promote angiogenesis in ischemic tissues. Overexpression of uPA was studied in rat myocardial infarction (MI) and mouse hind limb ischemia models and compared with VEGF overexpression effects. Animals were divided into control and three experimental groups (n = 6), receiving intramuscular injections of plasmids as follows: (i) control (empty vector or expressing β-galactosidase); (ii) uPA; (iii) VEGF165; (iv) a 1:1 mixture of uPA and VEGF165. The capillary densities in both ischemic models were greater (P < 0.05) in tissues treated with uPA, VEGF, or a combination of both than in controls. Infarct size was reduced in hearts from uPA and VEGF experimental groups compared with controls (P < 0.05). Local overexpression of uPA induced a marked increase in the number of macrophages and myofibroblasts present within infarcts. Hind limb blood flow was greater in all experimental groups by day 10 (P < 0.05). Overall, the effects of uPA and VEGF were uniformly comparable. Additional analysis revealed association of local edema with VEGF but not with uPA treatment. This study established that uPA gene therapy effectively induces functionally significant angiogenesis in models of acute MI and hind limb ischemia.",
author = "Traktuev, {Dmitry O.} and Tsokolaeva, {Zoya I.} and Shevelev, {Alexander A.} and Talitskiy, {Konstantin A.} and Stepanova, {Victoria V.} and Johnstone, {Brian H.} and Rahmat-Zade, {Tahmina M.} and Kapustin, {Alexander N.} and Tkachuk, {Vsevolod A.} and March, {Keith L.} and Parfyonova, {Yelena V.}",
year = "2007",
month = "11",
doi = "10.1038/sj.mt.6300262",
language = "English (US)",
volume = "15",
pages = "1939--1946",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle

AU - Traktuev, Dmitry O.

AU - Tsokolaeva, Zoya I.

AU - Shevelev, Alexander A.

AU - Talitskiy, Konstantin A.

AU - Stepanova, Victoria V.

AU - Johnstone, Brian H.

AU - Rahmat-Zade, Tahmina M.

AU - Kapustin, Alexander N.

AU - Tkachuk, Vsevolod A.

AU - March, Keith L.

AU - Parfyonova, Yelena V.

PY - 2007/11

Y1 - 2007/11

N2 - Urokinase plasminogen activator (uPA) is required for both endogenous and vascular endothelial growth factor (VEGF)-augmented angiogenesis in normal tissues, leading us to hypothesize that uPA augmentation by gene transfer might promote angiogenesis in ischemic tissues. Overexpression of uPA was studied in rat myocardial infarction (MI) and mouse hind limb ischemia models and compared with VEGF overexpression effects. Animals were divided into control and three experimental groups (n = 6), receiving intramuscular injections of plasmids as follows: (i) control (empty vector or expressing β-galactosidase); (ii) uPA; (iii) VEGF165; (iv) a 1:1 mixture of uPA and VEGF165. The capillary densities in both ischemic models were greater (P < 0.05) in tissues treated with uPA, VEGF, or a combination of both than in controls. Infarct size was reduced in hearts from uPA and VEGF experimental groups compared with controls (P < 0.05). Local overexpression of uPA induced a marked increase in the number of macrophages and myofibroblasts present within infarcts. Hind limb blood flow was greater in all experimental groups by day 10 (P < 0.05). Overall, the effects of uPA and VEGF were uniformly comparable. Additional analysis revealed association of local edema with VEGF but not with uPA treatment. This study established that uPA gene therapy effectively induces functionally significant angiogenesis in models of acute MI and hind limb ischemia.

AB - Urokinase plasminogen activator (uPA) is required for both endogenous and vascular endothelial growth factor (VEGF)-augmented angiogenesis in normal tissues, leading us to hypothesize that uPA augmentation by gene transfer might promote angiogenesis in ischemic tissues. Overexpression of uPA was studied in rat myocardial infarction (MI) and mouse hind limb ischemia models and compared with VEGF overexpression effects. Animals were divided into control and three experimental groups (n = 6), receiving intramuscular injections of plasmids as follows: (i) control (empty vector or expressing β-galactosidase); (ii) uPA; (iii) VEGF165; (iv) a 1:1 mixture of uPA and VEGF165. The capillary densities in both ischemic models were greater (P < 0.05) in tissues treated with uPA, VEGF, or a combination of both than in controls. Infarct size was reduced in hearts from uPA and VEGF experimental groups compared with controls (P < 0.05). Local overexpression of uPA induced a marked increase in the number of macrophages and myofibroblasts present within infarcts. Hind limb blood flow was greater in all experimental groups by day 10 (P < 0.05). Overall, the effects of uPA and VEGF were uniformly comparable. Additional analysis revealed association of local edema with VEGF but not with uPA treatment. This study established that uPA gene therapy effectively induces functionally significant angiogenesis in models of acute MI and hind limb ischemia.

UR - http://www.scopus.com/inward/record.url?scp=35548935641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548935641&partnerID=8YFLogxK

U2 - 10.1038/sj.mt.6300262

DO - 10.1038/sj.mt.6300262

M3 - Article

C2 - 17653104

AN - SCOPUS:35548935641

VL - 15

SP - 1939

EP - 1946

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 11

ER -